Whalegun
Home

Christopher R. Cline, CFO: Travere Therapeutics TVTX Sell · Filed 24/01/25

Trade details

Type
Insider sale
Amount
$7,736.71
Shares · price
853 sh · $9.07 a share
Held after
49,721 sh
Stock
Travere Therapeutics TVTX
Person
Christopher R. ClineCFO
Trade date
24/01/23
Filed
24/01/25
Days to filing
2 days

Sold 1.7% of holdings

Share of holding sold
1.7%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/24~24/02/22

Christopher R. Cline's recent trades

  • Christopher R. Cline

    Planned sale10b5-1 planTravere Therapeutics

    $3.3M

    Filed 09/15

  • Christopher R. Cline

    Sell10b5-1 planTravere Therapeutics

    $101.7K

    Filed 05/06

  • Christopher R. Cline

    Sell10b5-1 planTravere Therapeutics

    $13.6K

    Filed 05/06

  • Christopher R. Cline

    Planned sale10b5-1 planTravere Therapeutics

    $13.6K

    Filed 05/06

  • Christopher R. Cline

    Planned saleTravere Therapeutics

    $101.7K

    Filed 05/05